Pfizer Back For AstraZeneca? Year-end Move Seen Most Likely

Now watching

Next video starts in : 7 Play

Pfizer Back For AstraZeneca? Year-end Move Seen Most Likely

Pfizer Back For AstraZeneca? Year-end Move Seen Most Likely
Replay video
Up next

K-Pop Convention KCON Set To Invade East Coast In July

Unlock your personal NFL Now stream by signing in to NFL.com

Pfizer Back For AstraZeneca? Year-end Move Seen Most Likely

by Wochit 0:43 mins

Pfizer Back For AstraZeneca? Year-end Move Seen Most Likely

by Wochit 0:43 mins

Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion takeover attempt in May. But while British takeover rules mean deal talks could be back on the cards as early as August 26th, following the ending of the first of a two-stage cooling-off period, many investors and analysts see the year-end as a more likely time for any return. Dan Mahony, a fund manager at Polar Capital, who increased his stake in AstraZeneca last year, said "I'm not expecting anything next week."

Wochit

Other Space

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

  6. 27:02

    Other Space Episode 6: Powerless

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 30:58

    Community Episode 4: Queer Studies and Advanced Waxing

  5. 28:45

    Community Episode 5: Laws of Robotics and Party Rights

  6. 28:13

    Community Episode 6: Basic Email Security